JBJClass II

Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Methemoglobin Reduction

21 CFR 864.7360 / Hematology

JBJ is the FDA product code for Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Methemoglobin Reduction, a class II device type, regulated under 21 CFR 864.7360. As of 2026-09-10, FDA records hold no 510(k) clearances under this code and no recalls.

Classification record

Product code: JBJ
Device name: Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Methemoglobin Reduction
Regulation: 21 CFR 864.7360
Device class: Class II
Review panel: Hematology
Submission type: 510(k)
Implant: No
Life sustaining or supporting: No
GMP exempt: No
Third party review eligible: Yes
Ingested clearances: 0
Ingested recalls: 0

Companies listing this code with FDA

Companies whose registered establishments list this code

Nova Biomedical Corporation

Recent clearances

Product code JBJ

FDA records hold no clearances under product code JBJ.

Recent recalls

Product code JBJ

FDA records show no recalls under product code JBJ.

MDM coverage of this record lists here, newest first.

About this record

Sourced from the FDA device classification database, ingested from openFDA. The definition, regulation number, device class and review panel are FDA’s own fields, reproduced without editing.

MDM adds the counts: clearances by decision year, the applicants holding the most clearances under this code, recalls that name it, and the registered establishments that list it. Every count is computed from ingested records only.

Data as of 2026-10-05, the FDA export date for this dataset. Page last changed 2026-09-05. View this product code on fda.gov (opens on fda.gov)